New treatments for myasthenia: a focus on antisense oligonucleotides

Corrado Angelini, Martignago, Bisciglia
  • Drug Design Development and Therapy, January 2013, Taylor & Francis
  • DOI: 10.2147/dddt.s25716

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/dddt.s25716

The following have contributed to this page: Prof Corrado Angelini